Hippocratic AI valued at $3.5 billion in latest financing round

Reuters
2025/11/04
UPDATE 3-Hippocratic AI valued at $3.5 billion in latest financing round

Adds analyst comment in paragraph 10

By Pritam Biswas

Nov 3 (Reuters) - Hippocratic AI raised $126 million in its latest funding round led by Avenir Growth, it said on Monday, valuing the healthcare company at $3.5 billion and underscoring venture capital's strong interest in artificial intelligence-integrated companies.

Private funding has remained strong, as companies keep getting valued in billions by startup investors looking to capture the AI rush.

Global venture funding rose 38% year-on-year to $97 billion in the third quarter. 46% of all global venture funding in the third quarter went towards AI companies.

The round also saw participation from other investors, including Google's growth fund CapitalG, General Catalyst, A16z, Kleiner Perkins and Universal Health Services, among others.

"Their (Hippocratic AI's) rapid growth is a testament to the demand for solutions to our industry's labor and patient access crisis," said Julie Yoo, general partner at Andreessen Horowitz, in a statement.

The latest round — Series C — comes after the company raised $141 million at a valuation of $1.64 billion earlier in the year. The funds from the latest round were raised to fuel expansion through mergers, product development and international growth.

The Series C brings Hippocratic's total raise to $404 million.

Hippocratic AI was co-founded by CEO Munjal Shah alongside a group of physicians, hospital administrators, healthcare professionals and AI researchers from El Camino Health, Johns Hopkins, Stanford, Microsoft MSFT.O, Google GOOGL.O and NVIDIA NVDA.O.

The company has developed generative AI agents for healthcare and has partnered with over 50 healthcare organizations, such as Cleveland Clinic, Northwestern Medicine, Ochsner Health, Moffitt Cancer Center, University Hospitals and others.

"The company's near-doubling in value in less than a year, fueled by partnerships with over 50 major health systems, reflects extraordinary commercial traction and market fit," said Dimitri Zabelin, senior AI analyst at PitchBook.

GenAI is being deployed to boost operational efficiency across sectors, from banking and healthcare to industrial production.

(Reporting by Pritam Biswas in Bengaluru; Editing by Alan Barona)

((Pritam.Biswas@thomsonreuters.com))

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10